Home Newsfeeds ‘Instagram is expanding NFT features to more than 100 countries’ -Engadget Report

‘Instagram is expanding NFT features to more than 100 countries’ -Engadget Report

https://www.engadget.com/instagram-nft-expansion-154058568.html?src=rss

byBenzinga Newsdesk

August 4, 2022

1 minute read

https://www.engadget.com/instagram-nft-expansion-154058568.html?src=rss

Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

December 5, 2:06 PM

Shares of Daktronics, Inc. (NASDAQ: DAKT) moved lower during Tuesday’s session following weak quarterly results.

ACRV

Stora Enso Earlier Reported Q3 EPS $0.47 Up From $0.44 YoY, Sales $2.99B Down From $3.04B YoY

By Bill Haddad

October 21, 6:21 AM

Stora Enso (OTC:SEOAY) reported quarterly earnings of $0.47 per share. This is a 6.82 percent increase over earnings of $0.44 per share from the same period last year. The company reported $2.99 billion in sales this

SEOAY

Ainos, Inc. Announces 1-For-5 Stock Consolidation

By Benzinga Newsdesk

December 12, 9:03 AM

Ainos, Inc. (NASDAQ:AIMD, AIMDW)))) ("Ainos," or the "Company"), a diversified healthcare company focused on the development of AI-powered point-of-care testing, VELDONA® low-dose interferon therapeutics, and

AIMD

News

Altamira Therapeutics Says Positive Outlook For 2023, And Our Transformation Into A Pureplay RNA Therapeutics Company, Remains Unchanged Even Though Our Timeline Has Shifted Into The New Year

By Happy Mohamed

January 27, 9:52 AM

"Our positive outlook for 2023, and our transformation into a pureplay RNA therapeutics company, remains unchanged even though our timeline has shifted into the new year," said Thomas Meyer, Altamira's founder, Chairman and CEO.

CYTO

‘Instagram is expanding NFT features to more than 100 countries’ -Engadget Report

Related Posts

Why Daktronics Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

Stora Enso Earlier Reported Q3 EPS $0.47 Up From $0.44 YoY, Sales $2.99B Down From $3.04B YoY

Ainos, Inc. Announces 1-For-5 Stock Consolidation

Altamira Therapeutics Says Positive Outlook For 2023, And Our Transformation Into A Pureplay RNA Therapeutics Company, Remains Unchanged Even Though Our Timeline Has Shifted Into The New Year